Lifecore Biomedical, Inc. (LFCR)

Lifecore Biomedical Market Cap

Lifecore Biomedical has a market cap or net worth of $201.30 million as of April 19, 2024. Its market cap has increased by 75.66% in one year.

• Market Cap: 201.30M
• Enterprise Value: 288.73M
• 1-Year Change: 75.66%
• Ranking: #3645
• Category: Micro-Cap
• Stock Price: $6.58

Market Cap Chart

Since December 1, 1998, Lifecore Biomedical's market cap has increased from $51.30M to $201.30M, an increase of 292.41%. That is a compound annual growth rate of 5.53%.

Market Cap History

Date	Market Cap	% Change
Apr 18, 2024	192.90M	-3.31%
Apr 17, 2024	199.50M	-0.15%
Apr 16, 2024	199.80M	4.66%
Apr 15, 2024	190.90M	3.13%
Apr 12, 2024	185.10M	-1.80%
Apr 11, 2024	188.50M	5.48%
Apr 10, 2024	178.70M	-4.90%
Apr 9, 2024	187.90M	2.34%
Apr 8, 2024	183.60M	-2.13%
Apr 5, 2024	187.60M	0.37%
Apr 4, 2024	186.90M	-0.53%
Apr 3, 2024	187.90M	11.45%
Apr 2, 2024	168.60M	-4.69%
Apr 1, 2024	176.90M	9.06%
Mar 28, 2024	162.20M	2.72%
Mar 27, 2024	157.90M	0.19%
Mar 26, 2024	157.60M	-4.48%
Mar 25, 2024	165.00M	4.10%
Mar 22, 2024	158.50M	2.92%
Mar 21, 2024	154.00M	0.65%
Mar 20, 2024	153.00M	-29.82%
Mar 19, 2024	218.00M	0.14%
Mar 18, 2024	217.70M	-2.73%
Mar 15, 2024	223.80M	-0.67%
Mar 14, 2024	225.30M	-3.51%

View and export this data all the way back to 1998. Sign Up Today.

Related Stocks

Company	Market Cap
Acumen Pharmaceuticals	208.48M
Zevra Therapeutics	201.50M
Elevation Oncology	201.42M
Cardiff Oncology	201.05M
X4 Pharmaceuticals	200.69M
Generation Bio Co.	198.10M
Poseida Therapeutics	196.84M
Compass Therapeutics	195.05M